Global Retirement Partners’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$506 Hold
100
﹤0.01% 3996
2025
Q3
$1.03K Hold
100
﹤0.01% 3519
2025
Q2
$841 Buy
+100
New +$935 ﹤0.01% 3482
2024
Q4
$2.25K Hold
100
﹤0.01% 3035
2024
Q3
$3.75K Hold
100
﹤0.01% 2692
2024
Q2
$3.75K Hold
100
﹤0.01% 2734
2024
Q1
$3.36K Hold
100
﹤0.01% 2554
2023
Q4
$3.93K Hold
100
﹤0.01% 2423
2023
Q3
$3.09K Hold
100
﹤0.01% 2361
2023
Q2
$3.33K Hold
100
﹤0.01% 2354
2023
Q1
$4.2K Buy
+100
New +$8.02K ﹤0.01% 2227
2020
Q2
Sell
-9
Closed -$2K 1623
2020
Q1
$2K Hold
9
﹤0.01% 1393
2019
Q4
$0 Buy
9
+3
+50% +$88 ﹤0.01% 1628
2019
Q3
$0 Buy
+6
New +$199 ﹤0.01% 1609

Other funds holding CODX

Global Retirement Partners's CODX Position: Q4 2025 in Review

Global Retirement Partners held its Co-Diagnostics (CODX) position steady in Q4 2025 at 100 shares worth $506. The position accounts for ﹤0.01% of the portfolio, ranked #3996.

Global Retirement Partners first reported a position in CODX in Q3 2019 and has held it in 14 quarters since. The position peaked at $4.2K in Q1 2023. 30 funds tracked by Wall St. Rank hold CODX as of Q4 2025.

  • Global Retirement Partners held 100 shares of Co-Diagnostics worth $506 as of Q4 2025.
  • Global Retirement Partners left its Co-Diagnostics share count unchanged in Q4 2025.
  • Co-Diagnostics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3996 holding.
  • Global Retirement Partners first reported a position in Co-Diagnostics in Q3 2019 and has held it in 14 quarters since.
  • Global Retirement Partners's Co-Diagnostics position peaked at $4.2K in Q1 2023.
  • 30 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.